SIAS
ARLZ

Shine Investment Advisory Services’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Shine Investment Advisory Services’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-34
Closed – – 686
2018
Q2 		$0 Hold
34
– – ﹤0.01% 683
2018
Q1 		$0 Hold
34
– – ﹤0.01% 686
2017
Q4 		$0 Hold
34
– – ﹤0.01% 702
2017
Q3 		$0 Hold
34
– – ﹤0.01% 708
2017
Q2 		$0 Buy
+34
New +$49 ﹤0.01% 661

Other funds holding ARLZ

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Shine Investment Advisory Services's ARLZ Position: Q3 2018 in Review

Shine Investment Advisory Services sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q3 2018, closing a stake of 34 shares.

Shine Investment Advisory Services first reported a position in ARLZ in Q2 2017 and held it in 5 quarters. The position peaked at $0 in Q2 2018. 4 funds tracked by Wall St. Rank hold ARLZ as of Q3 2018.

  • Shine Investment Advisory Services reported no remaining Aralez Pharmaceuticals Inc. position as of Q3 2018 after selling out during the quarter.
  • Shine Investment Advisory Services sold 34 Aralez Pharmaceuticals Inc. shares in Q3 2018.
  • Shine Investment Advisory Services first reported a position in Aralez Pharmaceuticals Inc. in Q2 2017 and held it in 5 quarters.
  • Shine Investment Advisory Services's Aralez Pharmaceuticals Inc. position peaked at $0 in Q2 2018.
  • 4 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q3 2018.

Based on Shine Investment Advisory Services's 13F filing for Q3 2018, filed 13 Nov 2018.